Pharmaceutical industry: Investors unfazed by drug-patent expiry
Nature
.
2012 Jan 18;481(7381):265.
doi: 10.1038/481265d.
Authors
David Brindley
,
Brock Reeve
,
Chris Mason
PMID:
22258594
DOI:
10.1038/481265d
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug Industry / economics*
Drug Industry / trends*